Artivion | CRY - Zahlungsmittel Und Äquivalente

Aktienkurs
35.29
Täglich Wechseln
-1.10 -3.02%
Monatlich
-8.46%
Jährlich
45.53%
Q1 Prognose
35.04




Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 8.52B 1.01B 2025-12
Accuray USD 63.34M 5.93M 2025-09
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 64.91M 8.52M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Inogen USD 106.48M 2.79M 2025-09
Integra LifeSciences USD 235.05M 2.86M 2025-12
J&J USD 19.71B 1.48B 2025-12
Mesa Laboratories USD 28.98M 8.55M 2025-12
Orthofix International USD 82.02M 19.16M 2025-12
Pfizer USD 1.34B 295M 2025-09
ResMed USD 1.42B 33.22M 2025-12
Stryker USD 4.01B 755M 2025-12
Surmodics USD 36.11M 11.81M 2024-09
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Terumo JPY 217.16B 12.86B 2025-09
Trinity Biotech USD 1.34M 3.83M 2025-09